TRAINI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 694
EU - Europa 163
AS - Asia 94
Totale 951
Nazione #
US - Stati Uniti d'America 694
CN - Cina 54
IT - Italia 38
DE - Germania 31
UA - Ucraina 26
SE - Svezia 23
PL - Polonia 22
TR - Turchia 20
SG - Singapore 15
GB - Regno Unito 11
FI - Finlandia 6
IN - India 4
NL - Olanda 3
FR - Francia 2
ES - Italia 1
IR - Iran 1
Totale 951
Città #
Fairfield 121
Woodbridge 84
Ashburn 67
Houston 67
Chandler 56
Seattle 52
Wilmington 46
Jacksonville 34
Cambridge 33
Warsaw 22
Izmir 19
Ann Arbor 16
Nanjing 15
Bremen 13
Princeton 13
Milan 12
Dearborn 10
Ferrara 10
Shanghai 9
Beijing 8
San Diego 6
Singapore 6
Boardman 5
Tianjin 4
Los Angeles 3
Nanchang 3
New York 3
Shenyang 3
Delft 2
Des Moines 2
Forlì 2
Formigine 2
Guangzhou 2
Mumbai 2
Ningbo 2
Reggio Emilia 2
Vicenza 2
Ardabil 1
Changsha 1
Clifton 1
Delhi 1
Falls Church 1
Ferrara di Monte Baldo 1
Forest City 1
Hefei 1
Jiaxing 1
Kilburn 1
Kunming 1
Lanzhou 1
London 1
Lyon 1
Mcallen 1
Miami Beach 1
Munich 1
Norwalk 1
San Mateo 1
Santa Lucia Di Piave 1
Shaoxing 1
Taizhou 1
The Hague 1
Voghiera 1
Walnut 1
Washington 1
Yellow Springs 1
Totale 785
Nome #
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis 148
Co-spray dried resveratrol and budesonide inhalation formulation for reducing inflammation and oxidative stress in rat alveolar macrophages 132
Solid lipid microparticles as an approach to drug delivery 118
Quercetin Solid Lipid Microparticles: a flavonoid for inhalation lung delivery 104
Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study 91
null 86
Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection 85
The use of fatty acids as absorption enhancer for pulmonary drug delivery 79
The formulation of a novel macrolide solution pressurised metered dose inhaler: the use of Clarithromycin as an anti-inflammatory for bronchiectasis therapy 70
Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis 22
A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties 18
In vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation 17
Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler 15
Co-Spray-Dried Urea Cross-Linked Hyaluronic Acid and Sodium Ascorbyl Phosphate as Novel Inhalable Dry Powder Formulation 13
Totale 998
Categoria #
all - tutte 4.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020195 0 0 8 43 17 29 30 23 23 13 5 4
2020/2021211 9 7 6 24 5 6 34 20 14 53 26 7
2021/202294 2 4 6 3 17 8 2 5 8 12 5 22
2022/2023132 11 4 8 13 35 16 14 5 17 0 7 2
2023/202466 11 12 4 2 3 5 2 4 1 0 0 22
2024/202512 5 7 0 0 0 0 0 0 0 0 0 0
Totale 998